Search

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event In a case report, a 35-year-old woman and a 19-year-old woman were described, who developed anaphylaxis during treatment with house-dust-mite-allergy-immunotherapy for allergic rhinoconjunctivitis due to house dust mite (HDM) [ I dosages not stated i ]. Patient 2: A 19-year-old woman had a history of refractory rhinoconjunctivitis with an allergy to HDM, tree pollen, grass and pollen. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event An adult man [ I exact age at reaction onset not stated i ] developed anaphylaxis during treatment with ranitidine for diffuse/intense epigastric pain. On the second day of ranitidine therapy, two hours following the administration of ranitidine, he had angioedema of the face and generalised urticaria. The allergy specialist decided to treat his rhinitis symptoms with levocetirizine and fluticasone furoate until the end of grass pollen season and to re-evaluate the atopic status and a possible hypersensitivity reaction induced by ranitidine. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 10-year-old girl developed anaphylactic reaction and large local reaction (LRR) during allergy immunotherapy with artemisia/cynodon/fraxinus/populous-allergy-immunotherapy and cat-hair/helianthus/salsola/ulmus-allergy-immunotherapy. Therefore, the subsequent injection dose was not advanced until her injection reactions were within the guidelines, and she needed a prolonged up-dosing, which lasted ~8 months to achieve maintenance without any systemic reactions. She had developed LRR and anaphylactic reaction secondary to the treatment with allergy immunotherapy with artemisia/cynodon/fraxinus/populous-allergy-immunotherapy and cat-hair/helianthus/salsola/ulmus-allergy-immunotherapy. [Extracted from the article]

A 14-year-old girl developed anaphylaxis that manifested as a systemic reaction following treatment with timothy grass pollen allergen extract (Grastek) for the treatment of allergic rhinitis secondary to timothy grass pollen allergy. After discussion with her parents, her treatment was started with sublingual timothy grass pollen allergen extract tablet 2800BAU [timothy grass pollen tablet] as per the manufacturers protocol. [Extracted from the article]